Answers are grounded in this paper and cite their sources.
We have identified 5 upregulated DEGs (HMMR, CCNB1, CXCL8, MAD2L1, and CCNA2) in GC patients with poor prognosis using integrated bioinformatical methods, which could be potential biomarkers and therapeutic targets for GC treatment.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: